Home
About Us
Science
Programs
Careers
Contact
News
Contact
Back to News
Opportunities for Treg cell therapy for the treatment of human disease
You might also be interested in...
April 4, 2025
Tr1X Awarded $8 Million CIRM Grant to Support TRX103 Phase 1/2a Clinical Trial for Graft-Versus-Host Disease
View
View
April 1, 2025
Tr1X Announces Succession Plan: Appoints David de Vries CEO, Effective June 1; Bill Lis to Serve as Executive Chairman
View
View
January 9, 2025
NextGen: Class of 2025
View
View